CCTG Clinical Trials
Public Trial Select
Member Trial Select
Protecting Cancer Patients from COVID-19In the race to find new ways to prevent and treat COVID-19, CCTG has launched an innovative clinical trial focussed on strengthening the immune system for one of the most vulnerable populations – cancer patients. More >> |
Recently Activated Trials
Member Links
CCTG Announces Initiation of IND.239CCTG has announced the commencement of a Phase II study of CFI-400945, an oral, first-in-class inhibitor of Polo-like Kinase 4 in combination with durvalumab, a PD-L1 checkpoint inhibitor, in patients with advanced or metastatic triple negative breast cancer. More >> |
Planned Trials
Committees Select
Group newsletter: CCTG Connection
December 02, 2020
CCTG is recruiting for a Patient Representative Volunteer RolePublished: December 02, 2020Category: Group updates  The Canadian Cancer Trials Group (CCTG) is currently seeking applications for a Patient Representative for the Head and Neck Disease Site Committee (cancer inside the nose, throat or mouth). This is a volunteer role for membership on the Head & Neck General Committee, the Head & Neck Executive Committee, and the CCTG Patient Representative Committee. Patient Representatives participate in all aspects of their Site Committee activities, and collectively all Site Committee Patient Representatives make up the CCTG Patient Representative Committee. Read More |
November 18, 2020
Dr. Tony Reiman CCS Research Chair, University of New BrunswickPublished: November 18, 2020Category:  Congratulations to our CCTG Hematologic Disease Site Chair, Dr. Tony Reiman, who has been successfully reappointed as the Canadian Cancer Society Research Chair at the University of New Brunswick. Read More |
 CCTG would like to extend congratulations to Dr. Kelvin Chan the recipient of the 2020 Dr. Maurice McGregor Award from Canadian Agency for Drugs and Technologies in Health (CADTH). The Dr. Maurice McGregor Award, honours rising stars early in their careers. Read More |
 Great news to share from the CCTG IC8 trial team! The study already has 6 sites currently participating with 29 patients accrued. Congrats to all of the trial teams at: Read More |
November 04, 2020
|
|
 The CCTG Pharmacy Network is actively seeking pharmacy representation for the Genitourinary Disease Site Committee and the Steering Group - Quebec. Read More |
Call for Nominations: Canadian Cancer Society Awards for ExcellencePublished: November 04, 2020Category: News  The Canadian Cancer Society Awards for Excellence in Cancer Research recognize individuals who have made, and are making, valuable contributions to the cancer research ecosystem in Canada. Recipients are leaders in their fields who exemplify excellence in science and outstanding service to the scientific community. There are two new awards this year find out more here. Read More |
CCTG SC24 practice changing trial results presented at the ASTRO 2020 meetingPublished: November 04, 2020Category: News  Lead author Dr. Arjun Sahgal, deputy chief of radiation oncology at the Sunnybrook Health Sciences Centre of the University of Toronto, presented the findings from the CCTG SC24 at the American Society for Radiation Oncology (ASTRO) Annual Meeting last week. This randomized phase II/III trial is the first to show that stereotactic body radiation therapy is superior to conventional radiation treatments in alleviating pain from spinal metastases.
Read More |
